Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes


Autoria(s): SALES, Cristiane Hermes; PEDROSA, Lucia Fatima Campos; LIMA, Josivan Gomes; LEMOS, Telma Maria Araujo Moura; COLLI, Celia
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

Background & aims: This study was undertaken to assess magnesium intake and magnesium status in patients with type 2 diabetes, and to identify the parameters that best predict alterations in fasting glucose and plasma magnesium. Methods: A cross-sectional study was carried out in patients with type 2 diabetes (n = 51; 53.6 +/- 10.5 y) selected within the inclusion factors, at the University Hospital Onofre Lopes. Magnesium intake was assessed by three 24-h recalls. Urine, plasma and erythrocytes magnesium, fasting and 2-h postprandial glucose, HbA1, microalbuminuria, proteinuria, and serum and urine creatinine were measured. Results: Mean magnesium intake (9.37 +/- 1.76 mmol/d), urine magnesium (2.80 +/- 1.51 mmol/d), plasma magnesium (0.71 +/- 0.08 mmol/L) and erythrocyte magnesium (1.92 +/- 0.23 mmol/L) levels were low. Seventy-seven percent of participants presented one or more magnesium status parameters below the cut-off points of 3.00 mmol/L for urine, 0.75 mmol/L for plasma and 1.65 mmol/L for erythrocytes. Subjects presented poor blood glucose control with fasting glucose of 8.1 +/- 3.7 mmol/L, 2-h postprandial glucose of 11.1 +/- 5.1 mmol/L, and HbA1 of 11.4 +/- 3.0%. The parameters that influenced fasting glucose were urine, plasma and dietary magnesium, while plasma magnesium was influenced by creatinine clearance. Conclusions: Magnesium status was influenced by kidney depuration and was altered in patients with type 2 diabetes, and magnesium showed to play an important role in blood glucose control. (C) 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)[2006/05601-9]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)[135858/2006-2]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)[480487/2009-0]

Ministerio da Saude do Brasil

Fundacao de Apoio a Pesquisa do Estado do Rio Grande do Norte (FAPERN)[175_19969779]

Identificador

CLINICAL NUTRITION, v.30, n.3, p.359-364, 2011

0261-5614

http://producao.usp.br/handle/BDPI/19450

10.1016/j.clnu.2010.12.011

http://dx.doi.org/10.1016/j.clnu.2010.12.011

Idioma(s)

eng

Publicador

CHURCHILL LIVINGSTONE

Relação

Clinical Nutrition

Direitos

restrictedAccess

Copyright CHURCHILL LIVINGSTONE

Palavras-Chave #Magnesium #Diabetes #Assessment #Glucose control #Kidney function #Discriminant analysis #LOWER SERUM MAGNESIUM #DIETARY MAGNESIUM #MELLITUS TYPE-2 #RISK #INSULIN #WOMEN #MEN #CALCIUM #HEALTH #Nutrition & Dietetics
Tipo

article

original article

publishedVersion